| Group Lead, AI Products Engineering |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Global Category Manager Professional Services |
Hyderabad (Office) |
India |
Operations |
CTS |
Procurement |
אוק' 22, 2024 |
| National Customer Engagement Manager Dermatology |
Amsterdam |
Netherlands |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Customer Insights & Product Manager - Neurology & Immunology |
Warsaw |
Poland |
International |
Innovative Medicines |
Marketing |
אוק' 22, 2024 |
| Associate, Country QA Compliance |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Operations |
Innovative Medicines |
Quality |
אוק' 22, 2024 |
| Sr. eCompliance Specialist |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Quality |
אוק' 22, 2024 |
| Project Team Lead |
Mumbai (Head Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
אוק' 22, 2024 |
| Specialist - MS&T |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
אוק' 22, 2024 |
| Strategy Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Marketing |
אוק' 22, 2024 |
| Analyst Social Media Listening |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
אוק' 22, 2024 |
| Sr. Analyst - Social Media Listening |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
אוק' 22, 2024 |
| Maintenance Specialist |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Capability Building Manager |
Milano |
Italy |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
אוק' 22, 2024 |
| Medical Science Liaison |
Novosibirsk |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
אוק' 22, 2024 |
| Специалист по системе качества |
St. Petersburg (City) |
Russian Fed. |
Operations |
Innovative Medicines |
Quality |
אוק' 22, 2024 |
| Medical Advisor In Market Brands |
Vilvoorde |
Belgium |
International |
Innovative Medicines |
Research & Development |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Customer Engagement Manager - South East Netherlands |
Amsterdam |
Netherlands |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Operations |
Innovative Medicines |
Others |
אוק' 22, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 22, 2024 |
| Senior Regulatory Affairs Manager |
Vietnam |
Vietnam |
Development |
Innovative Medicines |
Research & Development |
אוק' 22, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Anqing (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
אוק' 23, 2024 |
| Cardiovascular Therapeutic Area Head |
Warsaw |
Poland |
International |
Innovative Medicines |
Commercial & General Management |
אוק' 23, 2024 |
| Business Planning Analysis Manager / Analyst |
INSURGENTES |
Mexico |
Biomedical Research |
CTS |
Audit & Finance |
אוק' 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Anqing (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
אוק' 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
אוק' 23, 2024 |
| Liaison en sciences médicales - Cancer du sein |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Research & Development |
אוק' 23, 2024 |
| Team Lead, Data Services |
Hyderabad (Office) |
India |
Operations |
CTS |
BD&L & Strategic Planning |
אוק' 23, 2024 |
| Quality Assurance Specialist |
Milano |
Italy |
Operations |
Innovative Medicines |
Quality |
אוק' 23, 2024 |
| Analitik (m/ž/d) / FRA Analyst (m/f/d) |
Ljubljana |
Slovenia |
Finance |
CTS |
Audit & Finance |
אוק' 23, 2024 |
| Data Steward |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
אוק' 23, 2024 |
| Customer Engagement Partner |
Taipei |
Taiwan |
International |
Innovative Medicines |
Sales |
אוק' 23, 2024 |
| Senior Principal Scientist |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
אוק' 23, 2024 |
| Manager - FC&C |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
אוק' 23, 2024 |
| Tactical Planner |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
אוק' 23, 2024 |
| Principal Scientist II |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
אוק' 23, 2024 |
| Analitik (m/ž/d) / FRA Analyst (m/f/d) |
Ljubljana |
Slovenia |
Finance |
CTS |
Audit & Finance |
אוק' 23, 2024 |
| Medical Director, Renal |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
אוק' 23, 2024 |
| Analitik (m/ž/d) / FRA Analyst (m/f/d) |
Ljubljana |
Slovenia |
Finance |
CTS |
Audit & Finance |
אוק' 23, 2024 |
| Associated Director – Senior Project Manager |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
אוק' 23, 2024 |